Probiotix Health (FRA:X90) Other Stockholders Equity: €-0.17 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Probiotix Health Other Stockholders Equity?

Probiotix Health FRA:X90 +0.72% Other Stockholders Equity is €-0.17 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Probiotix Health's Other Stockholders Equity for the quarter that ended in Dec. 2025 was €-0.17 Mil.

Probiotix Health's quarterly Other Stockholders Equity increased from Dec. 2024 (€-1.09 Mil) to Jun. 2025 (€-1.05 Mil) and increased from Jun. 2025 (€-1.05 Mil) to Dec. 2025 (€-0.17 Mil).

Probiotix Health's annual Other Stockholders Equity declined from Dec. 2023 (€-1.03 Mil) to Dec. 2024 (€-1.09 Mil) but then increased from Dec. 2024 (€-1.09 Mil) to Dec. 2025 (€-0.17 Mil).

Probiotix Health Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Probiotix Health's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Probiotix Health Other Stockholders Equity Chart

Probiotix Health Annual Data
Trend Dec18 Dec19 Dec20 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 0.14 -0.95 -1.03 -1.09 -0.17

Probiotix Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.03 -1.04 -1.09 -1.05 -0.17

Probiotix Health Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-0.17 Mil mean?
Probiotix Health (FRA:X90) has a Other Stockholders Equity of €-0.17 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Probiotix Health and its competitors.
Is Probiotix Health's Other Stockholders Equity too high?
Probiotix Health's current Other Stockholders Equity is €-0.17 Mil.
How does Probiotix Health's Other Stockholders Equity compare to VRTX and REGN?
Probiotix Health's Other Stockholders Equity of €-0.17 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Probiotix Health and its competitors. Probiotix Health's current Other Stockholders Equity is €-0.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Probiotix Health stock overvalued right now?
Probiotix Health (FRA:X90) has a current Other Stockholders Equity of €-0.17 Mil. The stock's GF Value™ is €0.09, compared to a current price of €0.07 — trading 22.2% below its estimated fair value. The current Other Stockholders Equity is €-0.17 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Probiotix Health (FRA:X90), the current Other Stockholders Equity is €-0.17 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Probiotix Health Business Description

Other Exchanges PBX:UK
Address Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB
Probiotix Health PLC is a life sciences company that develops probiotics to tackle cardiovascular disease and other lifestyle conditions that are affecting growing numbers of people across the world. The company has one class of business, in three geographical areas, being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry. Its geographical segments include the United Kingdom, the United States, and the Rest of the World. It generates the majority of its revenue from the United States.